US FDA's Generic Research May Include EpiPen And Competitors

Agency wants to acquire Auvi-Q and authorized generics for EpiPen and Adrenaclick, potentially for research on whether user interface affects substitutability.

female scientist working with microscope

The US FDA is looking to purchase a generic EpiPen and competing epinephrine products for testing in its labs, potentially to try to determine how competition for it and other combination products could enter the market.

Authorized generics for Mylan NV's EpiPen (epinephrine intramuscular injection) and Impax Laboratories Inc.'s Adrenaclick (epinephrine subcutaneous injection), as...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Generics

More from Biosimilars & Generics